Literature Review: The Effect of Zeaxanthin Carotenoid Supplementation on the Prevention of Age-Related Macular Degeneration (AMD)
DOI:
https://doi.org/10.54832/phj.v7i2.1192Keywords:
AMD: Age-Related Macular Degeneration, Carotenoid, zeaxanthinAbstract
Introduction: Age-Related Macular Degeneration (AMD) is a condition that harms the retina and primarily affects those who are 60 years old or older, leading to significant vision loss. In the United States, the count of individuals affected is projected to rise from 9.1 million in 2010 to approximately 17.8 million by the year 2050. The progression of AMD can be prevented by consuming sources of antioxidants which have been proven to inhibit the development of this disease. One type of antioxidant that is easy to find and abundant in nature is the carotenoid zeaxanthin.
Objectives: This study aimed explore the connection between the administration of carotenoid zeaxanthin and the prevention of Age-Related Macular Degeneration (AMD).
Methods: This research used a literature review method on research articles that have been conducted previously. Search for articles using the online databases PubMed and Sciencedirect. journal inclusion criteria for the last 5 years. A total of 5 articles were used in this study.
Results: The use of the carotenoid zeaxanthin showed a positive effect on preventing the development of Age-Related Macular Degeneration (AMD), yielding significant outcomes (p<0.05).
Conclusions: Administration of zeaxanthin supplementation has an effect on inhibiting the occurrence of Age-Related Macular Degeneration (AMD)
Downloads
References
Al-Zamil, W. M., & Yassin, S. A. (2017). Recent developments in age-related macular degeneration: a review. Clinical interventions in aging, 1313-1330.
Arunkumar, R., Gorusupudi, A., Li, B., Blount, J. D., Nwagbo, U., Kim, H. J., Sparrow, J. R., & Bernstein, P. S. (2021). Lutein and zeaxanthin reduce A2E and iso-A2E levels and improve visual performance in Abca4-/-/Bco2-/- double knockout mice. Experimental eye research, 209, 108680. https://doi.org/10.1016/j.exer.2021.108680
Budiono, S. (Ed.). (2019). Buku ajar ilmu kesehatan mata. Airlangga University Press.
Camelo, S., Latil, M., Veillet, S., Dilda, P. J., & Lafont, R. (2020). Beyond AREDS formulations, what is next for intermediate age-related macular degeneration (iAMD) treatment? Potential benefits of antioxidant and anti-inflammatory apocarotenoids as neuroprotectors. Oxidative Medicine and Cellular Longevity, 2020, 1-11.
Eisenhauer, B., Natoli, S., Liew, G., & Flood, VM. (2017). Lutein and zeaxanthin Food sources, bioavailability and dietary variety in age‐related macular degeneration protection. Nutrients; 9(2). Available from: https://doi.org/10.3390/nu9020120
Estrada, CG., Kosalkova, K., & Orejas, ICS. (2018). Extraction andmanalysis of carotenes and xanthophylls produce by xanthophyllomyces dendrorhous. Methods Mol Biol. 1852: 283-295. Available from: https://doi.org/10.1007/978-1-4939-8742-%209_17
Gheorghe, A., Mahdi, L., & Musat, O. (2015). Age-related macular degeneration. Romanian journal of ophthalmology, 59(2), 74.
Hirdyani, H., & Sheth, M. (2017). Lutein—The less explored carotenoid. World Journal of Pharmaceutical Research, 6(6), 528-553.
Jaggi, D., Solberg, Y., Dysli, C., Lincke, J., Habra, O., Wyss, A., Wolf, S., & Zinkernagel, M. (2023). Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study. Clinical nutrition ESPEN, 56, 127–134. https://doi.org/10.1016/j.clnesp.2023.05.009
Johra, F. T., Bepari, A. K., Bristy, A. T., & Reza, H. M. (2020). A mechanistic review of β-carotene, lutein, and zeaxanthin in eye health and disease. Antioxidants, 9(11), 1046.
Li, B., Vachali, P., Chang, F. Y., Gorusupudi, A., Arunkumar, R., Shi, L., Rognon, G. T., Frederick, J. M., & Bernstein, P. S. (2022). HDL is the primary transporter for carotenoids from liver to retinal pigment epithelium in transgenic ApoA-I-/-/Bco2-/- mice. Archives of biochemistry and biophysics, 716, 109111. https://doi.org/10.1016/j.abb.2021.109111
Li, X., Holt, R. R., Keen, C. L., Morse, L. S., Yiu, G., & Hackman, R. M. (2021). Goji Berry Intake Increases Macular Pigment Optical Density in Healthy Adults: A Randomized Pilot Trial. Nutrients, 13(12), 4409. https://doi.org/10.3390/nu13124409
Majeed, M., Majeed, S., & Nagabhushanam, K. (2021). An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration. Journal of medicinal food, 24(5), 551–557. https://doi.org/10.1089/jmf.2020.0097
Putri, A. V., Nurmalina, N., Sylvestris, A., & Hanifwati, A. (2022). Peran Karotenoid Sebagai Pencegahan Degenerasi Makula. ARTERI: Jurnal Ilmu Kesehatan, 4(1), 8-13.
Rupert, R. (2020). Cause of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidables blindness in relation to vision 2020: The right to sight: An analysis for the global burden of disease study. Lancet Glob Health. 9:144-60. doi:10.1016/S2214-109X(20)30489-7
Salimiaghdam, N., Riazi-Esfahani, M., Fukuhara, P. S., Schneider, K., & Kenney, M. C. (2019). Age-related macular degeneration (AMD): A review on its epidemiology and risk factors. The Open Ophthalmology Journal, 13(1).
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020). The role of inflammation in age-related macular degeneration. International Journal of Biological Sciences. 16(15): 2989–3001. Available from: https://doi.org/10.7150/ijbs.49890
Thomas, CJ., Mirza, RG,. & Gill, MK. (2021). Age-related macular degeneration. Med Clin North Am. 105:473–91.
